Telmisartan 80 mg Tablet

Adult dose

Essential hypertension: Administer 40 mg of telmisartan orally once daily with water, and it can be taken regardless of meals. In certain patients, a dose of 20 mg once daily may be effective. If necessary, the dose may be increased up to 80 mg once daily, with the maximum antihypertensive effect typically appearing 4 to 8 weeks after increasing the dose. Reduction of cardiovascular disease risk: 80 mg once daily.

This drug can cause serious harm, especially to the fetus and newborn, during pregnancy; it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals allergic to this drug or its components, pregnant or potentially pregnant women, breastfeeding women, patients with severe liver disease or cholestasis, patients with hereditary angioedema, and patients with diabetes or severe kidney disease. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, specific heart diseases, gastrointestinal disorders, renal artery hypertension, and severe kidney impairment should use this medication cautiously. During medication, various adverse reactions such as infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, cardiovascular abnormalities, respiratory distress, gastrointestinal disorders, liver function abnormalities, skin reactions, muscle pain, kidney impairment, etc., may occur; immediate consultation with healthcare professionals is advised if any unusual symptoms appear. Particularly, serious side effects such as angioedema, hyperkalemia, renal dysfunction, shock, or syncope, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, necessitating careful observation. Patients with renal impairment or decreased blood volume should thoroughly check their condition before taking this medication, and appropriate actions should be taken immediately if symptoms of hypotension arise. This drug may interact with other antihypertensive medications, certain diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to inform healthcare providers of any medications being taken. Women who are pregnant or breastfeeding are advised not to take this medication, and if it is necessary, it should be carefully decided after consulting a specialist. Safety and efficacy have not been established for children under 18 years; therefore, it is not recommended. Elderly patients should be carefully monitored for the risk of stroke and other complications due to excessive blood pressure lowering when taking this medication. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical attention and appropriate treatment should be sought. This medication should be kept out of reach of children and not transferred to other containers.

Serious side effects

Urticaria, severe swelling (angioedema), difficulty breathing (respiratory distress), cold sweat, pallor, severe rash with fever, blisters, skin peeling, painful mucous membranes of the mouth/eyes, severe skin reaction, shortness of breath or difficulty breathing, asthma attack, respiratory distress with cough+fever, yellowing of skin or eyes (jaundice), profound lethargy, liver abnormalities (jaundice), sudden and severe headache, lightning headache, seizure

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This drug should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance

White round tablet

Package unit

Bottle - 30 tablets/bottle